 Home > Active Ingredient News > Blood System > Focus on rare disease "thalassemia": FDA awards Mitapivat orphan drug title

Focus on rare disease "thalassemia": FDA awards Mitapivat orphan drug title

 Last Update: 2020-06-24
 Source: Internet
 Author: User

Tags

components red blood cells

chicken anemia

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Pharmaceutical company Agios announced today that the U.SFood and Drug Administration, theAdministration of(
FDA) has awarded acetone acid kinase-R (PKR) activator mitapivat for the treatment of thalassemia orphan drug titleMitapivat is a research small molecular deconstruction activator of wild and multi-mutant PKRDr Chris Bowden, Chief Medical Officer of Agios, said: "The acquisition of the orphan drug designation is an important milestone for AgiosWe will continue to promote Mitapivat therapy for thalassemia patientsThe latest data from the Mitapivat treatment of alpha and beta thalassemia II will be presented at the upcoming annual meeting of the European Society of Hematology (EHA)thalassemias is an inherited blood disorder that causes hemoglobin synthesis disorders, and its symptoms can vary according to type, to varying degrees from asymptomatic to severeCommonly thalassemia is accompanied by a typical symptom of anemia, namely low levels of red blood cellsAnemia can lead to feelings of fatigue and pale skin tone, as well as bone disease, spleen swelling, jaundice, dark urine, andgrowth delays in children

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality GMP / FDA Certificated Liraglutide Powder CAS 204656-20-2 Liraglutide

CAS No.: 204656-20-2

Pharmacy Grade

$30.00/G FOB

Pharma Grade CAS 224785-90-4 Vardenafil

CAS No.: 224785-90-4

Pharmacy Grade

$2-2.1/G FOB

Hot Selling Powder Flibanserin for for Women CAS 167933-07-5

CAS No.: 167933-07-5

Pharmacy Grade

$5-5.2/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.